跳至主要内容
临床试验/CTRI/2022/10/046402
CTRI/2022/10/046402招募中未知

A Retrospective, Observational Study to Determine Safety and performance of Neohexa-Sirolimus-Eluting Coronary Stent System (SES) in all-comer patients with coronary artery disease (CAD).

Sahajanand Laser Technology Ltd0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

入选标准

  • 1. Males and Females more than 18 years of age.
  • 2. Subjects who had signed the Hospital Consent Form.
  • 3. The subjects who have been treated with PCI and implanted with Neohexa Drug-Eluting Stent as a part of their treatment of Coronary Artery Disease without any further indication for emergent coronary artery bypass graft surgery
  • 4. Patients who have completed a minimum of 24 months after device implantation (device implanted between 01-01-2017 to 31-12-2019)

排除标准

  • 1. Subjects who are treated with stents other than Neohexa stent in the same vessel.
  • 2. Subjects implanted with Neohexa stent after 31-12-2019

研究者

发起方
Sahajanand Laser Technology Ltd

相似试验